| Literature DB >> 25282267 |
Clémence Tabélé1, Anita Cohen2, Christophe Curti1, Ahlem Bouhlel1, Sébastien Hutter2, Vincent Remusat1, Nicolas Primas1, Thierry Terme1, Nadine Azas2, Patrice Vanelle3.
Abstract
Following the promising antileishmanial results previously obtained in monoamidoxime series, a new series of derivatives was synthesized using manganese(III) acetate, Wittig reactions and Suzuki-Miyaura cross coupling reactions. Pharmacomodulation in R(1), R(2) or R(3) substituents on the amidoxime structure is shown to influence antiprotozoan activity in vitro: a monosubstituted phenyl group in R1 (32-35) led to an activity against Leishmania donovani promastigotes (32, IC50 = 9.16 μM), whereas a polysubstituted group (36-37) led to an activity against Plasmodium falciparum (36, IC50 = 2.76 μM). Modulating chemical substituents in R(2) and R(3) only influenced the antiplasmodial activity in vitro. This suggests that the amidoxime scaffold has properties that could make it a promising new antiparasitic pharmacophore.Entities:
Keywords: Amidoximes; Antiprotozoan activity in vitro; Cytotoxicity in vitro; Dihydrofuran; Manganese(III) acetate; Palladium-catalyzed coupling reactions; Pharmacomodulation
Mesh:
Substances:
Year: 2014 PMID: 25282267 DOI: 10.1016/j.ejmech.2014.07.113
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514